Clinical trial / 2009
Broccoli sprout sulforaphane increased antioxidant enzyme expression in the human upper airway
A placebo-controlled dose escalation trial evaluated oral sulforaphane from a standardized broccoli sprout homogenate in human subjects. Dosing safely produced dose-dependent increases in upper airway nasal lavage cell RNA expression for GSTM1, GSTP1, NQO1, and HO-1, peaking at the 200 g sprout dose. In contrast, ingestion of control alfalfa sprouts lacking sulforaphane failed to stimulate Phase II enzyme induction.
- Study type
- Placebo-controlled dose escalation trial
- Who was studied
- Human subjects
- What was measured
- Airway mucosal Phase II antioxidant enzyme expression
THE PAPER
Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway.
Riedl MA, Saxon A, Diaz-Sanchez D. Clin Immunol, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.